A Better Way to Amputate? The promise of agonist-antagonist myoneural interfaces

Congrats to the intrepid MIT-Harvard Biomechatronics lab.

Can  agonist-antagonist myoneural interfaces be a promising adjunct to current reconstructive/ablative/osteointegrative surgery? Read on here.

 

David G. Armstrong

Dedicated to amputation prevention, wound healing, diabetic foot, biotechnology and the intersection between medical devices and consumer electronics.

Leave a Reply